Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embracing Future HoldingsSGX:8YY -7.14% OCF Margin % is 0.00% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Embracing Future Holdings ranks worse than 78.92% on this metric.
The historical rank and industry rank for Embracing Future Holdings's OCF Margin % or its related term are showing as below:
SGX:8YY'
s OCF Margin % Range Over the Past 10 Years
Min: -709.75 Med: -201.52 Max: -6.85
Current: -54.98
During the past 11 years, the highest OCF Margin % of Embracing Future Holdings was -6.85%. The lowest was -709.75%. And the median was -201.52%.
SGX:8YY's OCF Margin % is ranked worse than 78.92% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs SGX:8YY: -54.98
Embracing Future Holdings OCF Margin % Related Terms
Embracing Future Holdings OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:8YY vs TMO, DHR, IDXX: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Embracing Future Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embracing Future Holdings OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Embracing Future Holdings's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Embracing Future Holdings's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embracing Future Holdings (SGX:8YY) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Embracing Future Holdings and its competitors. According to the industry distribution chart, Embracing Future Holdings ranks #161 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 78.9%.
Is Embracing Future Holdings' OCF Margin % too high?
Embracing Future Holdings' current OCF Margin % is 0.00%. Based on the distribution chart, Embracing Future Holdings ranks #161 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Embracing Future Holdings' OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Embracing Future Holdings ranks #161 out of 204 companies for OCF Margin %. This places Embracing Future Holdings in the lower half of its industry. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Embracing Future Holdings and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embracing Future Holdings's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embracing Future Holdings stock overvalued right now?
Embracing Future Holdings (SGX:8YY) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Embracing Future Holdings (SGX:8YY), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Embracing Future Holdings Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, Advertising, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports. Its operations are spread across Singapore, Japan, China, Europe, Hong Kong, Thailand, Malaysia, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:8YY has been successfully added to your 
